COVID-19 UPDATE: Florida announces re-open plans (5/4) -> 22 states = 38% GDP. Lessons from GFC -> Discretionary EBIT = ATH with 11% lower sales

COVID-19 remains a global crisis and we realize that many people need to keep up with COVID-19 developments, particularly since we are moving into the more critical stage ("restart economy"), so feel free to share our commentary to anyone who has interest.

There were three notable positive developments on the COVID-19 front today.  The biggest is the Phase 3 trial of Gilead's remdesivir, a government-funded study, found that patients who took remdesivir recovered faster than patients who did not from an average of 15 to 11 days. The improvements were so notable that the study was ended early and according to the NY Times, the FDA plans to announce an emergency-use authorization for remdesivir.  Ultimately, when effective treatments are developed for COVID-19, this will become another treatable ailment.  Thus, clearly a positive on the treatment front = reduce seriousness of COVID-19 = reduced consumer fear = re-open economy faster.  Also, NY Governor Cuomo accelerated further the re-start of NY state.  He announced today several NY counties, all of them upstate, will be permitted to resume elective surgeries, but only if they can keep 30% of their hospital beds and ICU beds free.  And Florida announced plans to re-open in phases beginning 5/...

Unlock this article with a FREE 30-Day Trial!

An FSI Pro, or FSI Macro subscription is required in order to access this content.

*Free trial available only on a monthly plan

More from the author

Disclosures (show)

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

🎁 Unlock 1 extra article by joining our Community!

You’ve reached your limit of 2 free monthly articles. Please enter your email to unlock 1 more articles.

Already have an account? Sign In

Don't Miss Out
First Month Free